OTC · Medical - Distribution

Amplifon S.p.A. (AMFPF) Stock

$11.21 +0.00% OTC: AMFPF Healthcare

Amplifon SpA engages in the distribution, application, and customization of hearing solutions. It contributes to the development of detection and rehabilitation techniques in otology diagnosis, and management of computerized and integrated auditory systems.

Valuation

MetricValue
Price$11.21
Market Cap$2.47B
P/E Ratio41.57
P/B Ratio2.17
P/S Ratio1.11
EPS (TTM)$0.27
52-Week High$18.33
52-Week Low$9.46
Dividend Yield3.03%

Financials & Margins

MetricValue
ROE6.34%
ROA2.01%
ROCE7.21%
Gross Margin8.59%
Operating Margin8.59%
Net Margin3.01%
Debt/Equity0.71
Current Ratio0.60

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.9B$2.1B$2.3B$2.4B$2.4B
Operating Profit$260.0M$276.0M$259.0M$257.0M$211.0M
Net Profit$158.0M$179.0M$155.0M$145.0M$91.0M
EPS$0.69$0.79$0.69$0.64$0.40
Op Margin13.3%13.0%11.5%10.7%8.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$3.5B$3.6B$3.7B$4.0B$3.9B
Total Liabilities$2.6B$2.5B$2.6B$2.8B$2.9B
Cash$269.0M$180.0M$193.0M$289.0M$309.0M
Borrowings$1.6B$1.5B$1.5B$1.7B$1.8B

Latest News

Earnings To Watch: Amplifon SpA (MIL:AMP) Q2 2026 -- GF Value Sees 161% Upside GuruFocus.com · Jul 29, 2026 European Value Picks: 3 Stocks Trading At An Estimated Discount Simply Wall St. · Jun 2, 2026 Is Amplifon (AMFPF) Stock Undervalued Right Now? Zacks · May 19, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$462.0M$459.0M$414.0M$451.0M$415.0M
Investing Cash Flow$-153.0M$-359.0M$-403.0M$-482.0M$-305.0M
Financing Cash Flow$-72.0M$-60.0M$-70.0M$-152.0M$-246.0M
Net Cash Flow$-276.0M$-89.0M$13.0M$96.0M$20.0M
Free Cash Flow$349.0M$343.0M$272.0M$305.0M$296.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.86
EV / EBITDA7.34
FCF Yield10.20%
Quick Ratio0.49
Interest Coverage3.49
Return 1Y-33.91%
Return 3Y-64.09%
Return 5Y—

Ownership

Insiders Held35.00%
Institutions Held20.79%
Institutions Float Held31.99%
Institutional HolderSharesReport Date
Pacer Advisors, Inc.6172025-12-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMBBYAmbu A/S $10.86 +0.00% 41.15 $2.89B 0.55%
BUGDFBumrungrad Hospital Public Company Limited $4.75 +0.00% 19.70 $3.78B 11.58%
BUHPFBumrungrad Hospital Public Company Limited $5.45 +0.00% 19.80 $4.33B 10.09%
CZMWFCarl Zeiss Meditec AG $35.81 +5.23% 22.43 $3.13B 1.76%
CZMWYCarl Zeiss Meditec AG $35.36 +0.60% 22.43 $3.10B 1.80%

About Amplifon S.p.A.

Amplifon SpA engages in the distribution, application, and customization of hearing solutions. It contributes to the development of detection and rehabilitation techniques in otology diagnosis, and management of computerized and integrated auditory systems. It operates through the following geographical segments: Europe, Middle East and Africa (EMEA), Americas, Asia-Pacific, and Corporate. The company was founded by Algernon Charles Holland in 1950 and is headquartered in Milan, Italy.

Amplifon S.p.A. is headquartered in IT.

Amplifon S.p.A. (AMFPF) stock trades at $11.21 with a market capitalization of $2.47B. The stock is valued at a price-to-earnings (P/E) ratio of 41.57, price-to-book of 2.17, price-to-sales of 1.11. Over the past 52 weeks the stock has ranged between $9.46 and $18.33, and currently trades 38.8% below its 52-week high. It pays a dividend yielding 3.03%.

On profitability, Amplifon S.p.A. generates a return on equity (ROE) of 6.34%, return on capital employed of 7.21%, an operating margin of 8.59%, a net profit margin of 3.01%.

Official website: www.amplifon.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides